Vladimir А. Gushchin

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov, Inna V. Dolzhikova, Dmitry V. Shcheblyakov et al. · The Lancet · 2021 · 1.8K citations · Full text

Vaccination, Vaccine Safety, Vaccinology +10

Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants

Vladimir А. Gushchin, Inna V. Dolzhikova, Andrei E. Siniavin et al. · Vaccines · 2021 · 118 citations · Full text

Rbd Domain, Immunology, Vaccine Hesitancy +18

Silencing of SARS‐CoV‐2 with modified siRNA‐peptide dendrimer formulation

Musa Khaitov, Alexandra Nikonova, I.P. Shilovskiy et al. · Allergy · 2021 · 113 citations · Full text

Non-labeled selective virus detection with novel SERS-active porous silver nanofilms fabricated by Electron Beam Physical Vapor Deposition

Nikolay N. Durmanov, Rustam R. Guliev, Arkady V. Eremenko et al. · Sensors and Actuators B Chemical · 2017 · 95 citations

Materials Science, Chemical Engineering, Engineering +6

Isolation and Characterisation of Alongshan Virus in Russia

Ivan S. Kholodilov, Alexander G. Litov, Alexander S. Klimentov et al. · Viruses · 2020 · 85 citations · Full text